Wintech Nano
688757
CHANGFU CO.,LTD
871396
DIER CHEMICAL
831304
CHENGUANG MEDICAL
430300
TLC
873576
(FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total operating revenue | 9.51%48.3B | 14.08%33.66B | 19.37%22.53B | 20.01%10.15B | 23.70%44.11B | 21.70%29.51B | 24.07%18.87B | 24.39%8.46B | 22.11%35.66B | 21.95%24.25B |
Operating revenue | 9.51%48.3B | 14.08%33.66B | 19.37%22.53B | 20.01%10.15B | 23.70%44.11B | 21.70%29.51B | 24.07%18.87B | 24.39%8.46B | 22.11%35.66B | 21.95%24.25B |
Other operating revenue | -18.74%343.59M | ---- | -5.83%64.85M | ---- | -5.78%422.83M | ---- | 10.45%68.86M | ---- | 4.70%448.78M | ---- |
Total operating cost | 9.01%43.95B | 13.56%30.29B | 18.22%20.34B | 16.61%9.26B | 21.17%40.32B | 20.72%26.67B | 21.34%17.2B | 19.85%7.94B | 23.10%33.27B | 20.71%22.09B |
Operating cost | 9.75%40.72B | 12.65%27.86B | 17.13%18.74B | 16.36%8.48B | 18.61%37.1B | 18.02%24.73B | 19.83%16B | 20.22%7.29B | 28.15%31.28B | 26.43%20.95B |
Operating tax surcharges | 25.78%83.48M | 45.65%51.42M | 34.45%31.88M | 50.60%8.98M | 36.10%66.38M | 40.54%35.3M | 39.02%23.71M | 9.69%5.96M | 41.26%48.77M | 20.55%25.12M |
Operating expense | -42.01%3.22M | -29.97%2.71M | -20.93%1.52M | -11.36%782.17K | -3.23%5.55M | -83.15%3.87M | -86.12%1.92M | -85.61%882.44K | -79.78%5.73M | 57.29%22.97M |
Administration expense | 9.28%1.13B | 14.71%701M | 22.26%463.49M | 1.67%205.95M | 18.89%1.04B | 15.47%611.12M | 16.54%379.11M | 31.66%202.56M | 20.53%871.75M | 15.01%529.22M |
Financial expense | -26.81%624.18M | 57.38%764.19M | 67.65%405.26M | 10.48%222.86M | 870.97%852.81M | 851.63%485.56M | 317.47%241.72M | -0.25%201.72M | -89.94%87.83M | -111.00%-64.6M |
-Interest expense (Financial expense) | -21.61%759.92M | -10.16%638.37M | -7.68%437.6M | 2.66%226.82M | 26.95%969.39M | 23.38%710.58M | 27.17%474.01M | 20.08%220.95M | -6.60%763.6M | -6.23%575.91M |
-Interest Income (Financial expense) | 34.63%-118.41M | 28.25%-91.31M | 22.27%-59.55M | 22.60%-34.69M | -46.75%-181.13M | -43.40%-127.26M | -64.15%-76.6M | -61.21%-44.81M | 0.40%-123.43M | 13.18%-88.74M |
Research and development | 10.45%1.38B | 12.97%913.98M | 24.75%700.8M | 41.72%334.36M | 28.20%1.25B | 28.57%809.01M | 35.20%561.75M | 23.73%235.93M | 1.85%978.11M | -3.02%629.25M |
Credit Impairment Loss | 110.76%6.09M | 226.03%23.53M | 124.41%4.56M | 804.18%556.36K | -14.45%-56.58M | -33.10%-18.67M | -27.71%-18.67M | --61.53K | -213.71%-49.43M | -457.92%-14.02M |
Asset Impairment Loss | 285.16%18.61M | -12.28%-4.31M | 12.11%-3.47M | 96.16%-366.42K | 55.72%-10.05M | 44.90%-3.84M | 56.40%-3.95M | 9.42%-9.54M | 98.87%-22.7M | 63.24%-6.96M |
Other net revenue | 2.73%484.62M | 13.38%390.76M | 41.12%306.94M | -22.08%109.84M | -23.21%471.73M | -29.33%344.64M | -43.05%217.5M | -46.08%140.97M | 147.45%614.31M | 13.41%487.68M |
Fair value change income | -39.41%43.1M | -31.95%42.58M | -24.66%42.58M | -2.62%32.36M | 9.00%71.14M | 9.41%62.58M | 5.13%56.52M | -14.50%33.23M | 4.02%65.26M | -3.42%57.19M |
Invest income | 13.83%219.98M | 28.67%154.39M | 15.16%96.96M | 20.68%36.4M | -36.40%193.26M | -47.17%120M | -52.04%84.19M | -61.69%30.16M | -27.23%303.87M | -10.75%227.14M |
-Including: Investment income associates | 22.64%218.69M | 41.95%153.1M | 29.56%95.8M | 22.04%34.57M | -37.99%178.31M | -50.23%107.85M | -56.89%73.95M | -64.02%28.33M | -22.91%287.56M | -2.37%216.68M |
Asset deal income | -240.69%-4.12M | -94.74%25.22K | -98.74%25.22K | 427.47%1.12M | 55.83%2.93M | -17.10%479.05K | 3,143.93%2M | 593.99%212.69K | 161.49%1.88M | 120.70%577.86K |
Other revenue | -25.86%200.96M | -5.19%174.54M | 70.73%166.28M | -54.20%39.77M | -14.07%271.04M | -17.73%184.09M | -44.77%97.39M | -43.77%86.85M | 21.12%315.43M | 59.20%223.75M |
Operating profit | 13.47%4.84B | 18.35%3.76B | 32.28%2.5B | 51.83%1B | 42.06%4.26B | 20.46%3.18B | 33.30%1.89B | 50.96%659.38M | 240.99%3B | 31.40%2.64B |
Add:Non operating Income | 155.20%293.2M | 26.16%117.07M | 122.89%88.49M | -56.91%6.22M | 49.93%114.89M | 168.86%92.8M | 25.22%39.7M | 62.38%14.44M | -77.19%76.63M | -52.80%34.51M |
Less:Non operating expense | 245.52%461.46M | 89.73%232.27M | 173.03%176.01M | 78.51%67.28M | 40.65%133.55M | 266.91%122.42M | 439.43%64.46M | 842.35%37.69M | -24.76%94.95M | -57.45%33.36M |
Total profit | 10.00%4.67B | 15.81%3.65B | 29.34%2.41B | 47.78%940.09M | 42.31%4.24B | 19.28%3.15B | 29.74%1.86B | 44.03%636.13M | 173.64%2.98B | 31.80%2.64B |
Less:Income tax cost | 32.07%1.27B | 46.55%1.01B | 72.09%699.4M | 38.76%249.45M | 99.11%960.24M | 32.02%689.31M | 25.38%406.41M | 32.63%179.76M | -37.16%482.27M | -3.34%522.14M |
Net profit | 3.55%3.4B | 7.19%2.64B | 17.41%1.71B | 51.33%690.64M | 31.35%3.28B | 16.14%2.46B | 31.01%1.46B | 49.07%456.37M | 676.03%2.5B | 44.77%2.12B |
Net profit from continuing operation | 3.55%3.4B | 7.19%2.64B | 17.41%1.71B | 51.33%690.64M | 31.35%3.28B | 16.14%2.46B | 31.01%1.46B | 49.07%456.37M | 676.03%2.5B | 44.77%2.12B |
Net income from discontinuing operating | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Less:Minority Profit | -2.70%262.11M | 2.98%191.78M | 0.20%117.26M | 5.44%55.13M | 91.72%269.37M | 272.20%186.22M | 1,897.32%117.03M | 2,164.43%52.28M | 1,483.36%140.51M | 387.50%50.03M |
Net profit of parent company owners | 4.11%3.14B | 7.54%2.44B | 18.92%1.59B | 57.27%635.51M | 27.75%3.01B | 9.94%2.27B | 21.12%1.34B | 33.00%404.09M | 653.15%2.36B | 42.35%2.07B |
Earning per share | ||||||||||
Basic earning per share | 4.10%0.6574 | 6.25%0.51 | 17.86%0.33 | 57.26%0.1332 | 27.76%0.6315 | 11.63%0.48 | 21.74%0.28 | 32.97%0.0847 | 653.51%0.4943 | 43.33%0.43 |
Other composite income | -250.40%-33.36M | 224.32%44.86M | 89.83%-7.74M | 346.73%7.5M | 97.07%-9.52M | 86.47%-36.08M | 38.04%-76.11M | -124.66%-3.04M | -2,048.99%-324.38M | -7,089.74%-266.63M |
Other composite income of parent company owners | -179.18%-36.94M | 210.15%47.48M | 89.12%-9.21M | 3,891.24%7.09M | 96.13%-13.23M | 85.05%-43.1M | 36.21%-84.63M | -101.43%-187.05K | -1,735.54%-341.77M | -6,009.88%-288.36M |
Other composite income of minority owners | -3.45%3.58M | -137.32%-2.62M | -82.75%1.47M | 114.45%412.4K | -78.66%3.71M | -67.70%7.02M | -13.40%8.52M | -259.97%-2.85M | 508.95%17.39M | 2,141.04%21.73M |
Total composite income | 2.83%3.37B | 10.64%2.68B | 23.33%1.7B | 54.00%698.15M | 50.50%3.27B | 30.92%2.42B | 39.59%1.38B | 42.34%453.33M | 542.12%2.17B | 26.22%1.85B |
Total composite income of parent company owners | 3.33%3.1B | 11.74%2.49B | 26.21%1.58B | 59.10%642.61M | 48.74%3B | 25.34%2.23B | 28.94%1.25B | 27.43%403.9M | 503.74%2.02B | 22.09%1.78B |
Total composite income of minority owners | -2.71%265.7M | -2.12%189.16M | -5.43%118.73M | 12.36%55.54M | 72.95%273.09M | 169.27%193.24M | 699.94%125.54M | 3,160.50%49.43M | 3,317.18%157.9M | 680.18%71.77M |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- |
Auditor | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.